As the cost of DNA sequencing decreases, association studies based on whole genome sequencing are now becoming feasible. It is still unclear, however, how much more we could gain from whole genome sequencing compared to exome sequencing, which has been widely used to study a variety of diseases. In this project, we performed a comparison between whole genome sequencing and exome sequencing for family-based association analysis using data from Genetic Analysis Workshop 18. Whole genome sequencing was able to identify several significant hits within intergenic regions. However, the increased cost of multiple testing counteracted the benefits and resulted in a higher false discovery rate. Our results suggest that exome sequencing is a cost-effective way to identify disease-related variants. With the decreasing sequencing cost and accumulating knowledge of the human genome, whole genome sequencing has the potential to identify important variants in regulatory regions typically inaccessible for exome sequencing.





Polls results
1

On a scale of 1 to 10, rate how much this article will change your clinical practice?

NO change
BIG change
33% Article relates to my practice (1/3)
66% Article does not relate to my practice (2/3)
0% Undecided (0/3)
2

Will this article lead to more cost-effective healthcare?

33% Yes (1/3)
33% No (1/3)
33% Undecided (1/3)
3

Was this article biased? (commercial or personal)

33% Yes (1/3)
66% No (2/3)
0% Undecided (0/3)
4

What level of evidence do you think this article is?

0% Level 1 (0/3)
33% Level 2 (1/3)
33% Level 3 (1/3)
33% Level 4 (1/3)
0% Level 5 (0/3)